Form 4 holding
Chief Global Commercialization Officer
Revolution Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 49,975
- Estimated value
- $7,802,057
- Report date
- 16 Jun 2026
- Price
- $156.12
- Ownership
- Direct